Quick Answer
Emergent BioSolutions Inc. reported Total Revenue of $742.90 million for fiscal year 2025.
Emergent BioSolutions Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $742.90M | -28.8% |
| 2024 | $1.04B | -0.5% |
| 2023 | $1.05B | -6.1% |
| 2022 | $1.12B | -37.0% |
| 2021 | $1.77B | +14.0% |
| 2020 | $1.56B | +40.6% |
| 2019 | $1.11B | +41.4% |
| 2018 | $782.40M | +39.5% |
| 2017 | $560.90M | +14.8% |
| 2016 | $488.80M | -0.1% |
| 2015 | $489.33M | +21.0% |
| 2014 | $404.47M | +29.3% |
| 2013 | $312.75M | +10.9% |
| 2012 | $281.89M | +3.1% |
| 2011 | $273.38M | -4.5% |
| 2010 | $286.17M | +21.9% |
| 2009 | $234.79M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $231.10M | -21.3% | +64.0% |
| June 30, 2025 | $140.90M | -44.7% | -36.6% |
| March 31, 2025 | $222.20M | -26.0% | -24.4% |
| September 30, 2024 | $293.80M | +8.6% | +15.4% |
| June 30, 2024 | $254.70M | -24.6% | -15.2% |
| March 31, 2024 | $300.40M | +82.8% | +11.1% |
| September 30, 2023 | $270.50M | +12.8% | -19.9% |
| June 30, 2023 | $337.90M | +39.3% | +105.7% |
- Emergent BioSolutions Inc. showed a decrease of -28.8% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, Emergent BioSolutions Inc.’s total revenue has grown by 216.4% (from $234.79 million to $742.90 million).
- The most recent figure is from Emergent BioSolutions Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: